Literature DB >> 10889830

Endocrine and paracrine-autocrine regulation of the human corpus luteum during the mid-luteal phase.

L Devoto1, M Vega, P Kohen, A Castro, O Castro, L K Christenson, P Carvallo, J F Strauss.   

Abstract

Human corpora lutea undergo an extremely rapid period of growth, development and regression during the course of non-fertile cycles. The tissue consists of steroidogenic (parenchymal) and non-steroidogenic (stromal) cells. In women and other primates, steroid hormone production by corpora lutea depends on the presence of pituitary-derived LH. Nevertheless, there is also intra-luteal regulation of steroid synthesis. Steroidogenic luteal cells and non-steroidogenic cells interact via endocrine and paracrine pathways, and by contact-dependent pathways (gap junctions). Thus, hormones and locally produced factors including steroids, growth factors, cytokines, reactive oxygen species and nitric oxide may modulate luteal lifespan. The factors regulating regression and rescue of the corpus luteum are not understood completely. This review describes the expression of two representative intragonadal peptides that may influence luteal regression (interleukin 1 beta) and luteal rescue (steroidogenic acute regulatory protein).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889830

Source DB:  PubMed          Journal:  J Reprod Fertil Suppl        ISSN: 0449-3087


  10 in total

Review 1.  Multiple signal transduction pathways regulate ovarian steroidogenesis.

Authors:  Jennifer R Wood; Jerome F Strauss
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Leptin interferes with 3',5'-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells.

Authors:  Qing Lin; Song Ling Poon; Junling Chen; Linan Cheng; Basil HoYuen; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2009-10-22       Impact factor: 5.211

3.  Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Authors:  Ya-Qin Wang; Jin Luo; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jin Yang
Journal:  J Ovarian Res       Date:  2015-09-23       Impact factor: 4.234

Review 4.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

5.  Assessment of the luteal phase in stimulated and substituted cycles.

Authors:  H M Fatemi
Journal:  Facts Views Vis Obgyn       Date:  2009

Review 6.  Perturbations in Lineage Specification of Granulosa and Theca Cells May Alter Corpus Luteum Formation and Function.

Authors:  Mohamed A Abedel-Majed; Sarah M Romereim; John S Davis; Andrea S Cupp
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 6.055

7.  Zika Virus Infection in the Ovary Induces a Continuously Elevated Progesterone Level and Compromises Conception in Interferon Alpha/Beta Receptor-Deficient Mice.

Authors:  Yingying Zhang; Ziyang Sheng; Na Gao; Na Wu; Peigang Wang; Dongying Fan; Deshan Zhou; Gong Cheng; Jing An
Journal:  J Virol       Date:  2021-11-03       Impact factor: 5.103

8.  To Compare the Effect of GnRH Agonist versus Human Chorionic Gonadotropin (HCG) Trigger on Clinical Pregnancy Rate in Intrauterine Insemination Cycle.

Authors:  Rashmi Sharma; Imlesh Meena
Journal:  J Hum Reprod Sci       Date:  2021-09-28

Review 9.  Cholesterol transport and steroidogenesis by the corpus luteum.

Authors:  Lane K Christenson; Luigi Devoto
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

10.  Profiling of luteal transcriptome during prostaglandin F2-alpha treatment in buffalo cows: analysis of signaling pathways associated with luteolysis.

Authors:  Kunal B Shah; Sudeshna Tripathy; Hepziba Suganthi; Medhamurthy Rudraiah
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.